Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug

Vilar-Gomez, EduardoChalasani, Naga2019-08-222019-08-222019Vilar-Gomez, E., & Chalasani, N. (2019). Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2019.06.032https://hdl.handle.net/1805/20525enPublisher PolicyNAFLDfibrosiscirrhosisDaily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old DrugArticle